Congress clears CDER ' s Office of New Drugs reorg

The FDA ' s CDER announced that the reorganization of certain offices within the New Drugs Regulatory Program (NDRP) has been approved by Congress.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news